31B Stock Overview
Engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Benchmark Holdings plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.39 |
| 52 Week High | UK£0.53 |
| 52 Week Low | UK£0.35 |
| Beta | 0.70 |
| 11 Month Change | -16.60% |
| 3 Month Change | -6.22% |
| 1 Year Change | 5.95% |
| 33 Year Change | -45.56% |
| 5 Year Change | -28.47% |
| Change since IPO | -40.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 31B | DE Food | DE Market | |
|---|---|---|---|
| 7D | -8.8% | -1.0% | -0.6% |
| 1Y | 5.9% | -11.2% | 9.6% |
Return vs Industry: 31B exceeded the German Food industry which returned -12.7% over the past year.
Return vs Market: 31B underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| 31B volatility | |
|---|---|
| 31B Average Weekly Movement | 7.7% |
| Food Industry Average Movement | 3.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 31B's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 31B's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 823 | Trond Williksen | www.benchmarkplc.com |
Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova.
Benchmark Holdings plc Fundamentals Summary
| 31B fundamental statistics | |
|---|---|
| Market cap | €329.12m |
| Earnings (TTM) | -€34.81m |
| Revenue (TTM) | €177.60m |
1.9x
P/S Ratio-9.5x
P/E RatioIs 31B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 31B income statement (TTM) | |
|---|---|
| Revenue | UK£147.51m |
| Cost of Revenue | UK£72.72m |
| Gross Profit | UK£74.79m |
| Other Expenses | UK£103.69m |
| Earnings | -UK£28.91m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 29, 2024
| Earnings per share (EPS) | -0.039 |
| Gross Margin | 50.70% |
| Net Profit Margin | -19.60% |
| Debt/Equity Ratio | 31.9% |
How did 31B perform over the long term?
See historical performance and comparison